Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001773751-24-000160 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-05 | 2024-06-03+ | HIMS | Baird Melissa | COO | S - Sale+OE | $20.54 | -105.8K | 541.4K | -16% | -$2.17M |
| DM | 2024-06-05 | 2024-06-03+ | HIMS | Baird Melissa | COO | M - OptEx | $0.4 | +105.8K | 559.1K | +23% | +$42.3K |
| DM | 2024-06-05 | 2024-06-03+ | HIMS | Baird Melissa | COO | M - OptEx | $0.00 | -105.8K | 634.4K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-06-05 | S | D | 3,562 | $21.66 | 541,432 | D | — | — | (F8) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.595 - $21.715. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2024-06-03 | S | D | 6,100 | $20.86 | 541,432 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.70 - $21.14. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2024-06-05 | S | D | 14,063 | $21.25 | 544,994 | D | — | — | (F7) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.60 - $21.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Class A Common Stock | 2024-06-03 | S | D | 64,406 | $20.32 | 547,532 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.715 - $20.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Class A Common Stock | 2024-06-03 | M | A | 70,506 | $0.4 | 611,938 | D | — | — | (F2) Includes 2,500 shares acquired on May 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan. |
| 6 | Common | Class A Common Stock | 2024-06-04 | M | A | 17,625 | $0.4 | 559,057 | D | — | — | |
| 7 | Common | Class A Common Stock | 2024-06-04 | S | D | 9,293 | $20.69 | 549,764 | D | — | — | (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.495 - $20.855. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Class A Common Stock | 2024-06-04 | S | D | 8,332 | $20.11 | 541,432 | D | — | — | (F6) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.50 - $20.49. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Common | Class A Common Stock | 2024-06-05 | M | A | 17,625 | $0.4 | 559,057 | D | — | — | |
| 10 | Derivative | Stock Option (right to buy) | 2024-06-04 | M | D | 17,625 | $0.00 | 616,777 | D | $0.4 · — to 2028-03-28 | 17,625 Class A Common Stock | (F9) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. |
| 11 | Derivative | Stock Option (right to buy) | 2024-06-05 | M | D | 17,625 | $0.00 | 599,152 | D | $0.4 · — to 2028-03-28 | 17,625 Class A Common Stock | (F9) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. |
| 12 | Derivative | Stock Option (right to buy) | 2024-06-03 | M | D | 70,506 | $0.00 | 634,402 | D | $0.4 · — to 2028-03-28 | 70,506 Class A Common Stock | (F9) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. |